Sinovac Adds Vaccine Capacity by Forming JV
November 25, 2009 at 04:35 AM EST
Sinovac Biotech (北京科兴生物制品有限公司) announced a new Joint Venture, Sinovac (Dalian) Vaccine Technology Co., Ltd., that will research, develop and produce human vaccines. Sinovac will contribute its vaccine expertise and capital, while Dalian Jin Gang Group will throw in land use rights, manufacturing facilities and established operating infrastructure. Representatives of Sinovac will fill the major operational posts in the JV. More details... Stock Symbol: (NSDQ: SVA)